← Field Guide
Japanese EncephalitisEast AsiaSouth AsiaSoutheast AsiaOceaniaPacific Islands

Japanese Encephalitis - Treatment and Prevention

Japanese Encephalitis is a mosquito-borne illness that US travelers to Asia should know about before their trip, and a safe, effective vaccine is available to help protect you.

Written by
WayPax Health
Published
June 30, 2026

Japanese encephalitis travel prevention for travelers

Japanese encephalitis (JE) is a serious brain infection caused by a virus spread through the bite of infected Culex mosquitoes. It is most common in rural farming areas across Asia, where travelers who spend time outdoors, especially near rice fields or pig farms, face the greatest risk. US travelers heading to affected regions should plan ahead, because a safe and effective vaccine is available before departure.

WayPax can write a prescription for the Japanese Encephalitis vaccine online, right now, before your trip.

WayPax Health is a full virtual travel clinic. A licensed travel health provider will review your itinerary and issue a real prescription without you ever setting foot in a clinic. No waiting rooms, no appointments to schedule in person.

Get your Japanese Encephalitis prescription and other travel medicines online today.

How to prevent Japanese encephalitis

The most effective way to prevent Japanese encephalitis is vaccination. The vaccine available in the United States is Ixiaro, an inactivated (killed-virus) vaccine given as two doses. For adults aged 18 to 65, the standard schedule is the first dose on day 0 and the second dose between days 7 and 28, according to NIH travel vaccination guidance. The vaccine is recommended for travelers who plan to spend a month or more in JE-risk areas, as well as shorter-term travelers who will have significant outdoor or rural exposure, per CDC Advisory Committee recommendations. Travelers with very short trips limited to urban areas may not need the vaccine, but a travel health provider should make that call based on your specific itinerary.

Beyond vaccination, mosquito bite prevention is essential. The Culex mosquito that carries JE bites most actively in the evening and at night. Use an EPA-registered insect repellent such as DEET or picaridin on exposed skin. Wear long sleeves and pants after dusk. Sleep under a bed net if your accommodation is not well screened. These steps work together with the vaccine to give you the best protection possible, as recommended by the WHO.

WayPax Health recommendation

WayPax Health carries Ixiaro, the only Japanese encephalitis vaccine licensed in the United States, and our licensed travel health providers can prescribe and arrange it for you entirely online. This is especially important for travelers heading to rural or agricultural areas of Asia, adventure travelers, backpackers, and anyone planning an extended stay in an endemic region. A WayPax provider will review your full itinerary, discuss your personal risk level, and issue a real prescription so you can get vaccinated and leave fully prepared. You get the same quality of care as a traditional travel clinic, with none of the hassle of scheduling an in-person visit. Do not wait until the week before your flight, because the two-dose Ixiaro series requires at least one week between doses.


Get your Japanese Encephalitis prescription and other travel medicines online today.

What is Japanese encephalitis?

Japanese encephalitis is a viral brain infection caused by the Japanese encephalitis virus (JEV), a flavivirus related to dengue, Zika, yellow fever, and West Nile viruses, according to the WHO fact sheet. The virus spreads to humans through the bite of infected Culex tritaeniorhynchus mosquitoes. These mosquitoes pick up the virus from animals, mainly pigs and wild birds, which act as the primary hosts. Humans are what scientists call "dead-end hosts," meaning the virus does not spread from person to person.

Most people infected with JEV have no symptoms at all, or only mild flu-like illness. However, in a small number of cases, the virus causes encephalitis (swelling of the brain). Symptoms of severe disease include sudden fever, headache, stiff neck, disorientation, seizures, and in some cases coma. Per NIH StatPearls research, the case-fatality rate among those who develop encephalitis can reach up to 30%, and 30 to 50 percent of survivors experience lasting neurological problems. The incubation period, meaning the time from mosquito bite to first symptoms, is typically 5 to 15 days, according to the CDC.

Where is Japanese encephalitis a risk?

Japanese encephalitis is primarily a disease of Asia and the Western Pacific. According to the WHO, 24 countries in the WHO South-East Asia and Western Pacific regions have ongoing JEV transmission, putting more than 3 billion people at potential risk of infection. The disease is most common in rural and agricultural settings, particularly in areas where rice farming and pig raising occur side by side, because these conditions support large mosquito populations and the animals that carry the virus.

Transmission is not evenly spread throughout the year. In many parts of Asia, JE cases peak during and just after the monsoon season, when standing water creates ideal breeding conditions for Culex mosquitoes. In tropical areas closer to the equator, transmission can occur year-round. Risk tends to be highest in rural lowland areas and lower in urban centers, though urban travelers are not entirely without risk if they venture into surrounding countryside.

The disease was first documented in Japan in 1871, but today it is found across a wide band of Asia, from the Indian subcontinent through Southeast Asia and into the Western Pacific islands. Travelers who spend time outdoors in rural areas of affected regions, particularly during evening and nighttime hours when the primary mosquito vector is most active, face the greatest exposure risk.

Treatment: what to do if you get Japanese encephalitis

There is no specific antiviral drug that treats Japanese encephalitis. As NIH research confirms, no targeted treatment exists, which makes prevention through vaccination and mosquito avoidance the most important steps a traveler can take. If a traveler develops symptoms of JE, including sudden fever, severe headache, confusion, or seizures, they should seek emergency hospital care immediately. Treatment in a hospital setting focuses on supporting the body while it fights the infection, managing fever, controlling seizures, and maintaining breathing if needed. The WHO notes that care is focused on relieving severe symptoms and helping the patient overcome the infection. Do not wait to see if symptoms improve on their own. Encephalitis (brain swelling) can worsen rapidly, and early hospital care gives the best chance of recovery.

Frequently asked questions

What are the symptoms of Japanese encephalitis in travelers?

Most people infected with the Japanese encephalitis virus have no symptoms or only mild flu-like illness. In the small number of cases that progress to encephalitis (brain swelling), symptoms include sudden high fever, severe headache, stiff neck, confusion, and in serious cases, seizures or loss of consciousness. According to the WHO, the case-fatality rate among those who develop encephalitis can be as high as 30 percent. If you develop any of these symptoms after traveling in a JE-risk area, seek emergency medical care right away.

How can I prevent Japanese encephalitis when traveling?

The best protection is getting vaccinated with Ixiaro before your trip. The two-dose series should be completed at least one week before you travel to a risk area. You should also use insect repellent containing DEET or picaridin, wear long sleeves and pants after dusk, and sleep in screened or air-conditioned rooms or under a bed net. Research published in PMC confirms that the Ixiaro vaccine is safe and effective for travelers. Combining vaccination with bite avoidance gives you the strongest possible protection.

Is there a vaccine for Japanese encephalitis for travelers?

Yes. Ixiaro is the Japanese encephalitis vaccine licensed for use in the United States. It is given as two doses, with the second dose administered between 7 and 28 days after the first. WayPax Health is a full virtual travel clinic where a licensed provider can review your itinerary and issue a real prescription for Ixiaro online, without you needing to visit a clinic in person. Start the process early so you have enough time to complete both doses before your departure.

Where is Japanese encephalitis a travel risk?

Japanese encephalitis is a risk across much of Asia and the Western Pacific. The WHO reports that 24 countries in the South-East Asia and Western Pacific regions have ongoing transmission. Risk is highest in rural agricultural areas, especially where rice farming and pig raising occur near each other. Urban travelers face lower but not zero risk, particularly if they take day trips into the countryside.

Can travelers get Japanese encephalitis from mosquito bites?

Yes. Japanese encephalitis spreads to humans through the bite of infected Culex mosquitoes, most commonly Culex tritaeniorhynchus. These mosquitoes are most active in the evening and at night. The virus does not spread from person to person, so you cannot catch it from another traveler or local resident. The CDC confirms that mosquito bite prevention, combined with vaccination, is the most effective way to reduce your risk.

How is Japanese encephalitis treated?

There is no specific antiviral medicine that cures Japanese encephalitis. Treatment in a hospital focuses on managing symptoms, controlling fever and seizures, and supporting breathing if needed. Per NIH guidance, no targeted antiviral treatment exists, which is why prevention before travel is so important. If you develop symptoms such as high fever, severe headache, or confusion after visiting a risk area, go to an emergency room immediately and tell the doctors where you traveled.

Who is most at risk of getting Japanese encephalitis while traveling?

Travelers who spend time in rural or agricultural areas of Asia and the Western Pacific face the highest risk, especially those who are outdoors in the evening or at night when the main mosquito vector is most active. Long-term travelers, backpackers, and people doing outdoor work or adventure activities in endemic regions are at greater risk than short-term urban visitors. CDC vaccine recommendations note that the JE vaccine is not typically needed for very short trips limited to urban areas, but a travel health provider should assess your specific itinerary.

Explore by region

South-East Asia

South Asia

East Asia and Western Pacific

Related diseases

  • Dengue fever (also spread by mosquitoes in Asia and the Western Pacific)
  • Malaria (mosquito-borne disease common across much of the same region)
  • Zika virus (mosquito-borne illness found in parts of Asia and the Pacific)
  • Chikungunya (mosquito-borne viral illness present across South-East Asia)
  • Tick-borne encephalitis (another flavivirus causing brain infection, found in parts of Asia)
Topics covered
Mosquito-BorneVaccine-PreventableAsia TravelRural AreasViral Infection
◆ Ready for your trip?

A WayPax provider can build a Trip Kit for your specific itinerary — prescriptions, destination guidance, and a Customs Declaration Letter, ready before you board.

Start your Trip Kit